The global HbA1c testing device market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing prevalence of diabetes and rising awareness about its complications. The increasing number of people with diabetes will drive the demand for HbA1c testing devices in the coming years.
The global HbA1c testing device market is segmented on the basis of type, application, and region. Based on type, it can be classified into Benctop, Compact, and Portable devices; based on application it can be classified into Hospital and Homecare; based on region it can be classified into North America (NA), Latin America (LA), Europe (EU), Asia Pacific (APAC) and Middle East & Africa (MEA).
- Increasing prevalence of diabetes and obesity in the population will drive the growth of the HbA1c Testing Device market.
- Increasing awareness about diabetes and its complications will also drive the growth of this market.
- The increasing number of people suffering from diabetes will increase demand for HbA1c Testing Devices.
- The increasing number of people suffering from type 2 diabetes will increase demand for HbA1c Testing Devices.
Industry Growth Insights published a new data on “HbA1c Testing Device Market”. The research report is titled “HbA1c Testing Device Market research by Types (Bench-top, Compact, Portable), By Applications (Hospital, Homecare, Other), By Players/Companies Abbott Laboratories, Roche, Siemens, Tosoh, Danaher Corporation, Bio-Rad Laboratories, Trinity Biotech, HUMAN Diagnostics, Arkray, OSANG Healthcare, Erba Diagnostics, PTS Diagnostics, GREEN CROSS MEDIS, Liteon Technology, DiaSys Diagnostic, EKF Diagnostics, Convergent Technologies”.
Scope Of The Report
Report Attributes
Report Details
Report Title
HbA1c Testing Device Market Research Report
By Type
Bench-top, Compact, Portable
By Application
Hospital, Homecare, Other
By Companies
Abbott Laboratories, Roche, Siemens, Tosoh, Danaher Corporation, Bio-Rad Laboratories, Trinity Biotech, HUMAN Diagnostics, Arkray, OSANG Healthcare, Erba Diagnostics, PTS Diagnostics, GREEN CROSS MEDIS, Liteon Technology, DiaSys Diagnostic, EKF Diagnostics, Convergent Technologies
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global HbA1c Testing Device Market Report Segments:
The global HbA1c Testing Device market is segmented on the basis of:
Types
Bench-top, Compact, Portable
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Homecare, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Roche
- Siemens
- Tosoh
- Danaher Corporation
- Bio-Rad Laboratories
- Trinity Biotech
- HUMAN Diagnostics
- Arkray
- OSANG Healthcare
- Erba Diagnostics
- PTS Diagnostics
- GREEN CROSS MEDIS
- Liteon Technology
- DiaSys Diagnostic
- EKF Diagnostics
- Convergent Technologies
Highlights of The HbA1c Testing Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Bench-top
- Compact
- Portable
- By Application:
- Hospital
- Homecare
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the HbA1c Testing Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A HbA1c testing device is a medical device used to measure the blood sugar levels of people with diabetes.
Some of the major players in the hba1c testing device market are Abbott Laboratories, Roche, Siemens, Tosoh, Danaher Corporation, Bio-Rad Laboratories, Trinity Biotech, HUMAN Diagnostics, Arkray, OSANG Healthcare, Erba Diagnostics, PTS Diagnostics, GREEN CROSS MEDIS, Liteon Technology, DiaSys Diagnostic, EKF Diagnostics, Convergent Technologies.
The hba1c testing device market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. HbA1c Testing Device Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. HbA1c Testing Device Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. HbA1c Testing Device Market - Supply Chain
4.5. Global HbA1c Testing Device Market Forecast
4.5.1. HbA1c Testing Device Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. HbA1c Testing Device Market Size (000 Units) and Y-o-Y Growth
4.5.3. HbA1c Testing Device Market Absolute $ Opportunity
5. Global HbA1c Testing Device Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. HbA1c Testing Device Market Size and Volume Forecast by Type
5.3.1. Bench-top
5.3.2. Compact
5.3.3. Portable
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global HbA1c Testing Device Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. HbA1c Testing Device Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Homecare
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global HbA1c Testing Device Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. HbA1c Testing Device Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global HbA1c Testing Device Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. HbA1c Testing Device Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global HbA1c Testing Device Demand Share Forecast, 2019-2026
9. North America HbA1c Testing Device Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America HbA1c Testing Device Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America HbA1c Testing Device Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Homecare
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America HbA1c Testing Device Market Size and Volume Forecast by Type
9.7.1. Bench-top
9.7.2. Compact
9.7.3. Portable
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America HbA1c Testing Device Demand Share Forecast, 2019-2026
10. Latin America HbA1c Testing Device Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America HbA1c Testing Device Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America HbA1c Testing Device Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Homecare
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America HbA1c Testing Device Market Size and Volume Forecast by Type
10.7.1. Bench-top
10.7.2. Compact
10.7.3. Portable
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America HbA1c Testing Device Demand Share Forecast, 2019-2026
11. Europe HbA1c Testing Device Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe HbA1c Testing Device Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe HbA1c Testing Device Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Homecare
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe HbA1c Testing Device Market Size and Volume Forecast by Type
11.7.1. Bench-top
11.7.2. Compact
11.7.3. Portable
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potenial Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe HbA1c Testing Device Demand Share, 2019-2026
12. Asia Pacific HbA1c Testing Device Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific HbA1c Testing Device Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific HbA1c Testing Device Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Homecare
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific HbA1c Testing Device Market Size and Volume Forecast by Type
12.7.1. Bench-top
12.7.2. Compact
12.7.3. Portable
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific HbA1c Testing Device Demand Share, 2019-2026
13. Middle East & Africa HbA1c Testing Device Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa HbA1c Testing Device Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa HbA1c Testing Device Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Homecare
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa HbA1c Testing Device Market Size and Volume Forecast by Type
13.7.1. Bench-top
13.7.2. Compact
13.7.3. Portable
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa HbA1c Testing Device Demand Share, 2019-2026
14. Competition Landscape
14.1. Global HbA1c Testing Device Market: Market Share Analysis
14.2. HbA1c Testing Device Distributors and Customers
14.3. HbA1c Testing Device Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott Laboratories
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Roche
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Siemens
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Tosoh
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Danaher Corporation
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Bio-Rad Laboratories
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Trinity Biotech
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. HUMAN Diagnostics
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Arkray
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. OSANG Healthcare
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Erba Diagnostics
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. PTS Diagnostics
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. GREEN CROSS MEDIS
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Liteon Technology
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. DiaSys Diagnostic
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. EKF Diagnostics
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Convergent Technologies
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
